SCHEMBL30950503

SCHEMBL30950503

CC(C)(C)c1noc(C(=O)NCc2ccc(-c3ccnc4[nH]c(-c5ccc(Cl)cc5N)nc34)cc2F)n1

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 20/20 0.59
▸ LCK P06239 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27458220 1.00 BTK (0.59) BTKLCK
SCHEMBL27456907 0.93 BTK (0.53) BTKLCK
SCHEMBL30950451 0.93 BTK (0.60) BTKLCK
SCHEMBL27457003 0.93 BTK (0.60) BTKLCK
SCHEMBL30950580 0.92 BTK (0.59) BTKLCK
SCHEMBL27457098 0.92 BTK (0.59) BTKLCK
SCHEMBL27456919 0.92 BTK (0.52) BTKLCK
SCHEMBL30950438 0.91 BTK (0.58) BTKLCK
SCHEMBL27457124 0.91 BTK (0.58) BTKLCK
SCHEMBL30950483 0.91 BTK (0.61) BTKLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024129395-A1 BTK INHIBITORS GWYNANT THERAPEUTICS, INC. (US) 2024-06-20 — — WO disclosed
Send feedback